Journal article

Management of locally recurrent nasopharyngeal carcinoma.

Anne WM Lee, Wai Tong Ng, Jimmy YW Chan, June Corry, Antti Mäkitie, William M Mendenhall, Alessandra Rinaldo, Juan P Rodrigo, Nabil F Saba, Primož Strojan, Carlos Suárez, Jan B Vermorken, Sue S Yom, Alfio Ferlito

Cancer Treat Rev | Published : 2019


As a consequence of the current excellent loco-regional control rates attained using the generally accepted treatment paradigms involving intensity-modulated radiotherapy for nasopharyngeal carcinoma (NPC), only 10-20% of patients will suffer from local and/or nodal recurrence after primary treatment. Early detection of recurrence is important as localized recurrent disease is still potentially salvageable, but this treatment often incurs a high risk of major toxicities. Due to the possibility of radio-resistance of tumors which persist or recur despite adequate prior irradiation and the limited tolerance of adjacent normal tissues to sustain further additional treatment, the management of l..

View full abstract

University of Melbourne Researchers